Identification of DPP4/CTNNB1/MET as a Theranostic Signature of Thyroid Cancer and Evaluation of the Therapeutic Potential of Sitagliptin

In recent years, the incidence of thyroid cancer has been increasing globally, with papillary thyroid cancer (PTCa) being the most prevalent pathological type, accounting for approximately 80% of all cases. Although PTCa has been regarded to be slow growing and has a good prognosis, in some cases, P...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Sheng-Yao Cheng, Alexander T. H. Wu, Gaber El-Saber Batiha, Ching-Liang Ho, Jih-Chin Lee, Halimat Yusuf Lukman, Mohammed Alorabi, Abdullah N. AlRasheedi, Jia-Hong Chen
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2022-02-01
Colecção:	Biology
Assuntos:	sitagliptin thyroid cancer (THCA) papillary thyroid cancer (PTCa) thyroidectomy metastasis drug resistance
Acesso em linha:	https://www.mdpi.com/2079-7737/11/2/324
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!